Overview of the latest MHRA Post-Transition Guidance
JensonR+ Regulatory Officer, Ben Smith talks through a bitesize overview of the latest MHRA Post-Transition Guidance in this helpful video.
Ben joined JensonR+ Ltd in October 2019 as regulatory officer, to support our clients with a wide range of regulatory activities from eCTD dossier creation to advice on borderline medicines.
Latest posts by Ben Smith (see all)
- Overview of the latest MHRA Post-Transition Guidance - October 20, 2020
- CAP Grandfathering - October 1, 2020
- 150 Days to the End of the Transition Period: A Focus on Centrally Authorised Products - August 3, 2020